What You Need to Know About the H1N1 Vaccine

H1N1 vaccine

We’ve received a number of questions and concerns about the swine flu and the H1N1 vaccine.¬†Indeed, a new survey by the Harvard School of Public Health finds that six in ten adults are not “absolutely certain” they will get the H1N1 vaccine, citing concerns over side effects, lack of perceived risk and belief that they could receive medication if they do get sick [1]. Just over half of parents surveyed report being “absolutely certain” they well get the vaccine for their children. To help disseminate credible information on the H1N1 vaccine and provide additional sources for review, we’ve put together¬†a list of questions and answers addressing what you need to know about the H1N1 vaccine.

H1N1 Vaccine Study Summaries: Single Dose Provides Protection

Preliminary results from two studies published online last week by the New England Journal of Medicine (NEJM) show that a single dose of the H1N1 vaccine will offer protection for most adults within three weeks of vaccination [1-2]. This is good news in the fight against H1N1, since the vaccine won’t be ready until the start of flu season. On Sunday, Health and Human Services Secretary Kathleen Sebelius said that some vaccine may be available as early as the first full week in October [3].